BC Innovations | Dec 6, 2016
Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Lipodystrophy Mouse and cell culture studies suggest inhibiting GPAT3 and/or GPAT4 could help treat congenital generalized lipodystrophy type 2, which is caused by mutations in BSCL2 . In a mouse model of the disease, levels...
BC Innovations | Feb 21, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Lipodystrophy Seipin; few lipid droplets (FLD) Studies in yeast suggest that targeting seipin in humans might help reverse some forms...
Items per page:
1 - 2 of 2